HEALTH, HAPPINESS AND LONGEVITY

HHAL MEDICAL NEWS OCTOBER 2009
Home | H-HAL-PEDIA | HHAL INDEX

HHAL MEDICAL NEWS OCTOBER 2009

 

Screening for Prostate and Breast Cancers

Have the benefits been overstated?

Screening for prostate and breast cancers has been promoted heavily in the U.S., and annual screening costs are US$20 billion for just these two cancers. Lifetime diagnoses ofprostate cancer were made in 1 of 11 white men in 1980; in 2009, the risk is 1 in 6. For breast cancer, risks were 1 in 12 in 1980 and 1 in 8 in 2009. Authors of a highly publicized review now challenge the value of such intensive screening.

If screening accurately identifies cancer at an early treatable stage, the incidence of localized cancer should increase after screening is implemented, and the incidence of metastatic cancer should decline. Because this pattern has occurred for neither breast nor prostate cancer, screening simply might identify low-risk non–life-threatening cancers that then are treated inappropriately with aggressive therapy. By comparison, screening for colon and cervical cancers has led to significantly fewer cases of advanced disease. The observed decline in prostate cancer–related mortality in the last 20 years probably is not attributable to screening but, rather, to aggressive new adjuvant therapies.

The costs associated with screening are substantial. For breast cancer, avoiding 1 cancer-related death requires annual screening of more than 800 women (age range, 50–70) for 6 years, which generates hundreds of biopsies and overly aggressive treatment for many patients with low-grade cancers.

The authors recommend greater focus on identifying new biomarkers that differentiate low- and high-risk cancers, minimalist approaches that are appropriate for treating patients with low-risk cancers, better tools to guide physicians and patients in informed decision making, and a greater focus on prevention and screening in high-risk patients rather than broad indiscriminate screening.

http://www.ncbi.nlm.nih.gov/pubmed/19843904?dopt=Abstract

 

To reduce weight, risk factors in the obese, try this
Liraglutide treatment over 20 weeks is well tolerated, induces weight loss, improves certain obesity-related risk factors, and reduces prediabetes.

http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(09)61375-1/abstract

 

What do higher C-peptide levels mean for nephropathy?
These authors demonstrate that higher C-peptide levels are associated with metabolic syndrome in patients with Type 2 diabetes and in diabetes patients who also had nephropathy and vascular disease. Masson/La Presse Medicale

http://www.em-consulte.com/article/227330

 

Medical exposure to radiation increased sixfold since 1980
The radiation exposure of U.S. patients from medical tests has increased sixfold since 1980, according to a new report in Radiology. About 380 million diagnostic and interventional radiological tests were conducted in the U.S. in 2006, in addition to 18 million nuclear medicine procedures.

http://health.usnews.com/articles/health/healthday/2009/10/27/radiation-from-medical-scans-soaring_print.htm

 

A postpartum diet that promotes weight loss?
Using a food-frequency questionnaire and recording the weights of 430 women for nine months postpartum, researchers found that participants on a high protein diet lost on average 316 grams more per month than those on a low protein diet. The article asks whether this should become standard practice after childbirth.

Conclusion

A reported higher protein intake may improve moderate postpartum body weight loss. Further studies should evaluate the long-term consequences of an HP diet postpartum.

http://www.nutritionjrnl.com/article/PIIS0899900709001269/fulltext

 

Phytoestrogens: A safe side-effect profile
Based on the available evidence, phytoestrogen supplements have a safe side-effect profile for treatment of the climacteric syndrome with moderately elevated rates of gastrointestinal side effects. Rates of vaginal bleeding, endometrial hyperplasia, endometrial cancer and breast cancer were not significantly increased among phytoestrogen users in the investigated studies.

Conclusions

Based on the available evidence, phytoestrogen supplements have a safe side-effect profile with moderately elevated rates of gastrointestinal side effects. Rates of vaginal bleeding, endometrial hyperplasia, endometrial cancer, and breast cancer were not significantly increased among phytoestrogen users in the investigated studies.

http://www.amjmed.com/article/S0002-9343(09)00542-7/fulltext

 

How bad for the heart is psychosocial stress? And how do you reduce it?
Psychosocial stress is an independent risk factor for mortality in patients with coronary artery disease, and exercise training can effectively reduce its prevalence. Exercise training reduces mortality in patients with coronary artery disease, and this effect seems to be mediated in part because of the salutary effects of exercise on psychosocial stress.

Conclusion

Psychosocial stress is an independent risk factor for mortality in patients with coronary artery disease, and exercise training can effectively reduce its prevalence. Exercise training reduces mortality in patients with coronary artery disease, and this effect seems to be mediated in part because of the salutary effects of exercise on psychosocial stress.

http://www.amjmed.com/article/S0002-9343(09)00439-2/fulltext

 

What's the relationship between moderate alcohol consumption and heart disease in hypertensives?
Alcohol has diverse effects on the cardiovascular system. Moderate drinking is associated with a reduced risk of cardiovascular disease, and yet increasing amounts of alcohol consumption are known to elevate blood pressure. Data from this study demonstrated an inverse relationship between moderate alcohol consumption and coronary heart disease in hypertensive men. 

 

In conclusion, our data demonstrated an inverse relation between moderate alcohol consumption and CHD in hypertensive men.

http://www.ajconline.org/article/S0002-9149(09)01103-5/fulltext

 

Research links diabetes with antioxidants
Antioxidants, the compounds in foods that can prevent cell damage, might increase the risk of Type 2 diabetes, according to a study published in Cell Metabolism. Research in mice indicated that the antioxidants remove a mechanism that can help the body use insulin

 

http://www.reuters.com/article/healthNews/idUSTRE5955Z620091006

 

Study: Depression less likely among those on Med diet
A study published in the Archives of General Psychiatry followed more than 10,000 adults in Spain and found that those who were on a Mediterranean diet were 42% to 51% less likely to suffer from depression. Although the diet, which is rich in fish, fruits, vegetables, whole grains and nuts, might help prevent depression, researchers say it should not be used to treat people who have been diagnosed with the condition.

http://healthday.com/Article.asp?AID=631618

 

Hormone replacement therapy and lung cancer deaths
Although treatment with oestrogen plus progestin in postmenopausal women did not increase incidence of lung cancer, it increased the number of deaths from lung cancer, in particular deaths from non-small-cell lung cancer. These findings should be incorporated into risk–benefit discussions with women considering combined hormone therapy, especially those with a high risk of lung cancer. 

Interpretation

Although treatment with oestrogen plus progestin in postmenopausal women did not increase incidence of lung cancer, it increased the number of deaths from lung cancer, in particular deaths from non-small-cell lung cancer. These findings should be incorporated into risk—benefit discussions with women considering combined hormone therapy, especially those with a high risk of lung cancer.

 

http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(09)61526-9/abstract

 

The benefits of chocolate: Only the beginning?


Evidence shows that chocolate can lower blood pressure, reduce systemic inflammation, inhibit cavities, increase cerebral blood flow and stimulate the central nervous system. This article details how some particular qualities of cocoa remain unexplained.

http://www.nutritionjrnl.com/article/PIIS0899900709002342/fulltext

 

Diabetes raises atrial fibrillation risk for women
A Kaiser Permanente study in Diabetes Care that compared 17,372 diabetic patients to nondiabetics found 3.6% of those who had diabetes got atrial fibrillation, compared with 2.5% of nondiabetics. Researchers said men in both groups had higher fibrillation rates than women but only among women did diabetes specifically increase the risk.

http://www.nytimes.com/2009/09/29/health/29risk.html?_r=2&ref=health&pagewanted=print

 

Midlife obesity raises health risks for women later
Obese middle-aged women are 79% more likely to suffer from chronic health problems and impaired mental fitness, compared with their slimmer counterparts, by the time they turn 70, a study in BMJ found. Every 2.2 pounds of extra weight lowered the odds of healthy survival by 5%, researchers said.

http://healthday.com/Article.asp?AID=631452

 

Diabetes Prevention Interventions Have Long-Lasting Effects

The benefits of lifestyle intervention or metformin for preventing the development of diabetes in high-risk adults can persist for 10 years, according to a follow-up report from the Diabetes Prevention Program (DPP) trial published online in Lancet.

Researchers examined longer-term follow-up data on some 2800 high-risk adults who had been randomized to intensive lifestyle intervention, metformin, or placebo in the DPP trial. At the end of that period (roughly 3 years), both lifestyle intervention and metformin had significantly lowered diabetes incidence relative to placebo (by 58% and 31%, respectively). Then, all participants were offered lifestyle counseling; those originally assigned to lifestyle intervention received additional lifestyle support, while the metformin group continued their treatment.

Over a median of 10 years' total follow-up, benefits of the interventions persisted — overall diabetes incidence was reduced by 34% in the lifestyle group and by 18% in the metformin group, relative to placebo.

 

http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(09)61457-4/fulltext

 

Migraine with Aura Linked to Increased Stroke Risk

Patients who suffer migraine with aura face twice the risk for ischemic stroke as those with migraine without aura, according to an industry-funded meta-analysis in BMJ.

Researchers analyzed 25 studies examining associations between migraine and cardiovascular risk. Among the findings:

    Overall migraine was associated with increased risk for stroke; however, the association appeared limited to migraine with aura.

    Female migraineurs had greater overall stroke risk than males.

    Stroke risk was further increased in migraineurs younger than 45, those who smoked, and those who used oral contraceptives.

Migraine was not associated with risk for MI or cardiovascular death.

An editorialist notes: "The absolute risk of stroke for most patients with migraine is low, so a doubling of risk is not cause for panic." She adds that while some experts recommend against using oral contraceptives in women with migraine with aura, the benefits of treatment should be weighed against the harms in women without additional stroke risk factors.

http://www.bmj.com/cgi/content/full/339/oct27_1/b3914

 

Midlife Overweight and Obesity Predict Lower Chance for Healthy Survival After Age 70

For every unit of BMI >25 kg/m2 at midlife, odds for disease-free survival at age 70 decreased by 12%.

Evidence strongly suggests that overweight (body-mass index, 25–30 kg/m2) and obesity (BMI, >30) are associated with risk for premature death. However, how adiposity affects health among those who actually survive to old age is less clear. Using data from the prospective Nurses' Health Study (NHS), investigators examined the associations between healthy survival (i.e., free from major chronic diseases, including myocardial infarction, cancer, and stroke) in old age and adiposity in early adulthood or midlife.

More than 17,000 women who were healthy at NHS enrollment in 1976 (mean baseline age, 50) and who survived beyond age 70 were included in the study. About 1700 women were still healthy at age 70. After adjustment for confounders, increasing BMI at baseline was associated inversely with odds for healthy survival beyond age 70. For example, women who were obese at baseline had 79% lower odds for healthy survival than did lean women. For every 1 unit of BMI >25, odds for healthy survival decreased by 12%. Also, women who reported gaining weight from age 18 to midlife had less chance for healthy survival than did women whose weight was stable. For every 1 kg of weight gained since age 18, odds for healthy survival were reduced by 5%. Unsurprisingly, healthy survival was lowest among women who were overweight at baseline and who gained  10 kg.

http://www.ncbi.nlm.nih.gov/pubmed/19789407?dopt=Abstract

                                                  

Incremental Cardiovascular Benefits of Increased HDL

Raising HDL levels, by whichever treatment, is associated with decreased risk for coronary events, according to an Archives of Internal Medicine study.

Researchers examined public-domain data on some 450 patients — participants of the Framingham Offspring Study — who started lipid-lowering therapy between 1975 and 2003. (The analysis was supported and partially conducted by a drug manufacturer.)

After an average follow-up of 8 years, the hazard ratio for suffering a coronary event was lowest among those experiencing the greatest increase in HDL relative to baseline. A 1% increase in HDL was associated with a 2% decrease in risk. The effect remained significant after adjustment for pretreatment HDL levels, age, and sex.

Conclusions  Raising HDL-C levels with commonly used lipid medications appears to be an important determinant of the benefits associated with lipid therapy. These results support the further evaluation of therapies to raise HDL-C levels to prevent CV events.

.http://archinte.ama-assn.org/cgi/content/abstract/169/19/1775

 

Abdominal Aortic Aneurysm: Short-Term Outcomes After Endovascular vs. Open Repair

Endovascular repair of abdominal aortic aneurysms carries a lower likelihood of perioperative death than open repair — a mortality advantage that disappears by the 2-year mark — according to an interim report of a 9-year study in JAMA.

Researchers randomized nearly 900 patients (aged 49 or older) from Veterans Affairs hospitals to either endovascular or open repair.

Mortality during hospitalization or at 30 days was significantly lower with the endovascular approach; however, at the 2-year mark, mortality did not differ significantly between the groups. In addition, the groups did not differ in self-reported measures of health-related quality of life or in the incidence of erectile dysfunction at 2 years.

Conclusions As compared with open repair, endovascular repair of abdominal aortic aneurysm is associated with lower short-term rates of death and complications. The survival advantage is more durable among older patients. Late reinterventions related to abdominal aortic aneurysm are more common after endovascular repair but are balanced by an increase in laparotomy-related reinterventions and hospitalizations after open surgery.

http://content.nejm.org/cgi/content/short/358/5/464

 

Predicting Stroke in Patients with Asymptomatic Carotid Stenosis?

Patients who already have CT evidence of silent embolic infarcts are most likely to benefit from surgery.

In randomized trials of carotid endarterectomy for asymptomatic carotid stenosis, surgery lowered stroke risks by only a few percentage points in men and not at all in women. Now, an international prospective observational study suggests one way to select patients most likely to benefit from surgery.

The study involved 821 patients (40% women; median age, 71) with carotid stenosis  50% and no history of ipsilateral stroke or transient ischemic attack. All patients underwent computed tomography brain scanning; CT findings suggestive of silent ischemic events were classified as "embolic" or "nonembolic," according to a published classification scheme. During a mean follow-up of 45 months, 6% of patients experienced ipsilateral hemispheric strokes. In patients with 60% to 99% stenosis, annual stroke rates were significantly higher among those with silent embolic infarcts on baseline CT than among those without such infarcts (3.6% vs. 1.0%).

 

Breast Tenderness After Starting Combination Hormone Therapy May Indicate Higher Breast Cancer Risk

Postmenopausal women who experience new-onset breast tenderness after starting combination hormone therapy may face increased risk for breast cancer, according to an Archives of Internal Medicine study.

Researchers examined data on some 17,000 Women's Health Initiative participants who were randomized to receive estrogen-progestin or placebo daily. In the hormone group, women with new-onset breast tenderness at 12 months were about 50% more likely to be diagnosed with breast cancer during 5.6 years' follow-up, relative to those without tenderness. (There was no such association among placebo recipients.)

The sensitivity and specificity of breast tenderness for predicting cancer risk were 41% and 64%, respectively — which, the authors say, are similar to values for the Gail model.

The authors note that hormone-induced elevations in serum estrone and estrone sulfate might lead to increased breast tenderness and heightened cancer risk. They add that their findings "should be considered by ... prescribing physicians to inform decisions regarding continued combined hormone therapy."

 

Herpes Zoster Linked to Increased Risk for Stroke

A patient's risk for stroke increases during the year after a herpes zoster attack, according to a retrospective study published online in Stroke.

Using a national database, researchers in Taiwan examined the incidence of stroke in some 7800 adults who had herpes zoster attacks and 23,000 matched controls. During 1 year of follow-up, stroke occurred in 1.7% of zoster patients and 1.3% of controls (adjusted hazard ratio, 1.3). Patients with zoster and ophthalmic complications were at especially high risk (adjusted HR, 4.3).

The association between zoster and stroke was limited to patients aged 45 and older.

The authors write: "Although varicella zoster virus vasculopathy is a well-documented complication ... it does not fully account for the unexpectedly high risk of stroke in these patients."

Conclusion—The risk for stroke increased after a zoster attack. Although varicella zoster virus vasculopathy is a well-documented complication that may induce a stroke postherpes zoster attack, it does not fully account for the unexpectedly high risk of stroke in these patients.

http://stroke.ahajournals.org/cgi/content/abstract/STROKEAHA.109.562017v1?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&fulltext=kang&searchid=1&FIRSTINDEX=0&resourcetype=HWCIT

 

 

A Third of Patients with Chronic Back Pain Recover Within a Year

A third of patients may completely recover from chronic lower back pain by 9 months, according to aBMJ study.

Researchers enrolled some 400 patients who presented to general practitioners, physiotherapists, or chiropractors soon after experiencing low back pain and who had persistent pain at 3 months. The patients were followed for 1 year. By 9 months, some 35% had fully recovered (i.e., they were pain-free, had no back-related disability, and had fully returned to work), and by 12 months, 41% had.

The following groups were at increased risk for delayed recovery: those with previous sick leave related to low back pain, high disability levels at enrollment, lower education levels, and a higher perceived risk for persistent pain.

http://www.bmj.com/cgi/content/full/339/oct06_2/b3829

 

Vitamin D Supplementation Linked to Decreased Risk for Falls

High doses of supplemental vitamin D may lower the risk for falls in older adults, reports a BMJmeta-analysis.

Researchers examined data from eight randomized controlled trials of supplemental vitamin D (vitamin D2 or D3) in roughly 2400 adults aged 65 or older. Among the findings:

         Supplemental vitamin D at 700 to 1000 IU/day (but not lower doses) was associated with a significant, 19% reduction in falls relative to no supplementation.

Serum vitamin D concentrations of 60 nmol/L or higher were associated with a 23% drop in falls (lower concentrations showed no significant association).

Researchers also looked at two trials of some 600 older adults and active vitamin D, a metabolite that may be more readily available for people with diminished kidney function. The reduction in falls was similar to that seen with supplemental vitamin D. However, patients taking the active form were more likely to experience hypercalcemia than controls.

As a potential underlying mechanism, the authors note that vitamin D has direct effects on muscle strength.

http://www.bmj.com/cgi/content/full/339/oct01_1/b3692

 

Is Clinical Breast Examination, Added to Mammography, Worthwhile?

CBE was associated with 55 additional false-positives for each additional breast cancer detected.

Whether patients benefit when clinical breast examination (CBE) is added to screening mammography is unclear. Canadian researchers addressed this issue in an analysis of data from the Ontario Breast Screening Program, a network of screening centers. Two thirds of centers offer CBE (performed by specially trained nurses) plus mammography; one third offer mammography only.

Nearly 300,000 women (age range, 50–69) were screened during 2 years. Mammography plus CBE resulted in slightly higher rates of cancer detection, but also higher false-positive rates, than mammography alone. The authors calculate that, for every 10,000 screened women, 59 cancers were diagnosed with mammography alone, and 63 were diagnosed with CBE plus mammography. Thus, CBE detected 4 additional cancers per 10,000 women screened but also generated 219 additional false-positives (women referred for further evaluation who ultimately did not have cancer) per 10,000 screened women.

CONCLUSIONS: Women should be informed of the benefits and risks of having a CBE in addition to mammography for breast screening.

http://www.ncbi.nlm.nih.gov/pubmed/19720967?dopt=Abstract

 

 

 

 

 

 

 

 

 

 

.

 

 

 

 

 

 

 

“Share your knowledge. It’s a way to achieve immortality.”